Pranlukast

• Background :

  Pranlukast is a selective Leukotriene CysLT1 antagonist1 and has been used in the treatment of asthma2. Pranlukast is also an inhibitor of GPR173 (IC50’s = 10.5nM hGPR17, 31nM rGPR17) and is superior to Montelukast in achieving functional inhibition4.

• Conjugation :

  Unconjugated

• Buffer :

  White solid

• Storage Conditions :

  RT